Page last updated: 2024-08-26

nicotine and Pulmonary Sarcoidosis

nicotine has been researched along with Pulmonary Sarcoidosis in 5 studies

Research

Studies (5)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	2 (40.00)	29.6817
2010's	1 (20.00)	24.3611
2020's	2 (40.00)	2.80

Authors

Authors	Studies
Bhargava, M; Maier, LA; Mroz, MM	1
Baran, J; Crouser, ED; Culver, DA; Diaz, C; Erdal, BS; Hade, EM; Julian, MW; Martin, K; Smith, RM	1
Ask, K; Bargagli, E; Kayser, G; Kirschbaum, A; Kolb, M; Müller-Quernheim, J; Prasse, A; Renkl, AC; Schulz, G; Stahl, M; Wang, L; Weiss, JM; Yalcintepe, J; Zissel, G	1
Baughman, RP; Bhatt, NY; Cosmar, DG; Crouser, ED; Culver, DA; Huang, Q; Julian, MW; Schlesinger, LS; Shao, G; Wood, KL	1
Floto, RA; Smith, KG	1

Trials

2 trial(s) available for nicotine and Pulmonary Sarcoidosis

Article	Year
A Pilot Randomized Trial of Transdermal Nicotine for Pulmonary Sarcoidosis. Chest, 2021, Volume: 160, Issue:4 Topics: Administration, Cutaneous; Adult; Disease Progression; Double-Blind Method; Female; Forced Expiratory Volume; Humans; Lung; Male; Middle Aged; Nicotine; Nicotinic Agonists; Pilot Projects; Sarcoidosis, Pulmonary; Tobacco Use Cessation Devices; Tomography, X-Ray Computed; Vital Capacity	2021
Nicotine treatment improves Toll-like receptor 2 and Toll-like receptor 9 responsiveness in active pulmonary sarcoidosis. Chest, 2013, Feb-01, Volume: 143, Issue:2 Topics: Antigens, Surface; Female; Forkhead Transcription Factors; Humans; Immunity, Cellular; Male; Middle Aged; Nicotine; Nicotinic Agonists; Phenotype; Sarcoidosis, Pulmonary; T-Lymphocytes, Regulatory; Toll-Like Receptor 2; Toll-Like Receptor 9; Treatment Outcome	2013

Article

Year

A Pilot Randomized Trial of Transdermal Nicotine for Pulmonary Sarcoidosis.

Chest, 2021, Volume: 160, Issue:4

Topics: Administration, Cutaneous; Adult; Disease Progression; Double-Blind Method; Female; Forced Expiratory Volume; Humans; Lung; Male; Middle Aged; Nicotine; Nicotinic Agonists; Pilot Projects; Sarcoidosis, Pulmonary; Tobacco Use Cessation Devices; Tomography, X-Ray Computed; Vital Capacity

2021

Nicotine treatment improves Toll-like receptor 2 and Toll-like receptor 9 responsiveness in active pulmonary sarcoidosis.

Chest, 2013, Feb-01, Volume: 143, Issue:2

Topics: Antigens, Surface; Female; Forkhead Transcription Factors; Humans; Immunity, Cellular; Male; Middle Aged; Nicotine; Nicotinic Agonists; Phenotype; Sarcoidosis, Pulmonary; T-Lymphocytes, Regulatory; Toll-Like Receptor 2; Toll-Like Receptor 9; Treatment Outcome

2013

Other Studies

3 other study(ies) available for nicotine and Pulmonary Sarcoidosis

Article	Year
Smoke Signals: Promise of Nicotine as a Treatment for Pulmonary Sarcoidosis. Chest, 2021, Volume: 160, Issue:4 Topics: Humans; Nicotiana; Nicotine; Sarcoidosis, Pulmonary; Smoke; Smoking	2021
Essential role of osteopontin in smoking-related interstitial lung diseases. The American journal of pathology, 2009, Volume: 174, Issue:5 Topics: Adult; Aged; Animals; Blotting, Western; Bronchoalveolar Lavage Fluid; Female; Histiocytosis, Langerhans-Cell; Humans; Idiopathic Pulmonary Fibrosis; Immunoenzyme Techniques; Lung Diseases, Interstitial; Macrophages, Alveolar; Male; Middle Aged; Nicotine; Osteopontin; Prognosis; Rats; Rats, Sprague-Dawley; Receptors, Nicotinic; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Sarcoidosis, Pulmonary; Smoking	2009
The vagus nerve, macrophages, and nicotine. Lancet (London, England), 2003, Mar-29, Volume: 361, Issue:9363 Topics: Acupuncture Therapy; alpha7 Nicotinic Acetylcholine Receptor; Alveolitis, Extrinsic Allergic; Humans; Immune Tolerance; Interleukin-1; Macrophage Activation; Nicotine; Receptors, Nicotinic; Sarcoidosis, Pulmonary; Smoking; Tumor Necrosis Factor-alpha; Vagus Nerve	2003